XPENG Announces Vehicle Delivery Results for January 2024
February 01, 2024 04:00 ET
|
XPeng Inc.
8,250 vehicles delivered in January 2024, a 58% increase year-over-year 2,478 units of X9 delivered in the first month of customer deliveries GUANGZHOU, China, Feb. 01, 2024 (GLOBE NEWSWIRE) --...
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
January 31, 2024 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
SPZI: JP 3E Holdings, Inc. Engaged Jason B. Meyer as Corporate Legal Partner; Introduces Jason Hoon Chang and Miguel Alcala
January 30, 2024 13:01 ET
|
JP 3E Holdings, Inc.
SPZI: JP 3E Holdings, Inc. Engaged Jason B. Meyer as Corporate Legal Partner; Introduces Jason Hoon Chang and Miguel Alcala
SPZI: JP 3E Holdings, Inc. Names Highly Qualified Board Member; Michel Verdy
January 16, 2024 14:28 ET
|
JP 3E Holdings, Inc.
SPZI: JP 3E Holdings, Inc. Names Highly Qualified Board Member; Michel Verdy
Baidu Responds to Recent Media Reports on Ernie Bot
January 15, 2024 09:44 ET
|
Baidu
BEIJING, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with strong Internet...
SPZI: JP 3E Holdings, Inc. Names Another Prominent Board Member - Daniel Lee
January 12, 2024 11:00 ET
|
Spooz, Inc.
SPZI: JP 3E Holdings, Inc. Names Another Prominent Board Member - Daniel Lee
SPZI: JP 3E Holdings, Inc. Names Two Prominent Board of Directors; Rolf Bela Wenz and Kisoo Kim
January 10, 2024 10:38 ET
|
Spooz, Inc.
SPZI: JP 3E Holdings, Inc. Names Two Prominent Board of Directors; Rolf Bela Wenz and Kisoo Kim
SPZI: Five New Fully Executed Commodity Contracts; Year to Date Total $303 Million
January 05, 2024 10:32 ET
|
Spooz, Inc.
SPZI: Five New Fully Executed Commodity Contracts; Year to Date Total $303 Million
Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China
January 05, 2024 08:00 ET
|
Praxis Precision Medicines, Inc.
Collaboration leverages Tenacia’s expertise in central nervous system drug development and commercialization and will address a significant unmet patient need Praxis to receive upfront proceeds of...
XPENG Launches X9 Ultra Smart Large Seven-seater in China
January 01, 2024 09:01 ET
|
XPeng Inc.
XPENG Launches X9 Ultra Smart Large Seven-seater in China